HeadInvest LLC’s Merck MRK Stock Holding History

HeadInvest LLC’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.72M	Sell	14,276 -1,722	-11%	-$199K	0.35%	68
2025 Q4	$1.68M	Buy	15,998 +3,062	+24%	+$287K	0.33%	68
2025 Q3	$1.09M	Sell	12,936 -672	-5%	-$55.3K	0.22%	85
2025 Q2	$1.08M	Sell	13,608 -1,718	-11%	-$137K	0.23%	82
2025 Q1	$1.38M	Sell	15,326 -6,036	-28%	-$564K	0.27%	78
2024 Q4	$2.13M	Sell	21,362 -493	-2%	-$50.8K	0.4%	61
2024 Q3	$2.48M	Sell	21,855 -410	-2%	-$48.7K	0.46%	55
2024 Q2	$2.76M	Sell	22,265 -812	-4%	-$105K	0.54%	46
2024 Q1	$3.05M	Sell	23,077 -2,430	-10%	-$300K	0.59%	48
2023 Q4	$2.78M	Sell	25,507 -551	-2%	-$57.2K	0.58%	45
2023 Q3	$2.67M	Sell	26,058 -186	-0.7%	-$20K	0.58%	44
2023 Q2	$2.82M	Sell	26,244 -1,348	-5%	-$153K	0.61%	46
2023 Q1	$2.94M	Buy	27,592 +549	+2%	+$59.3K	0.64%	43
2022 Q4	$3M	Sell	27,043 -374	-1%	-$38.2K	0.67%	43
2022 Q3	$2.36M	Sell	27,417 -400	-1%	-$35.7K	0.57%	46
2022 Q2	$2.54M	Buy	27,817 +550	+2%	+$48.8K	0.56%	46
2022 Q1	$2.24M	Buy	27,267 +23	+0.1%	+$1.81K	0.43%	53
2021 Q4	$2.09M	Sell	27,244 -109	-0.4%	-$8.68K	0.37%	57
2021 Q3	$2.05M	Sell	27,353 -168	-0.6%	-$12.8K	0.39%	53
2021 Q2	$2.14M	Sell	27,521 -1,129	-4%	-$84K	0.41%	52
2021 Q1	$2.11M	Buy	28,650 +734	+3%	+$54.1K	0.43%	52
2020 Q4	$2.18M	Buy	27,916 +5,564	+25%	+$426K	0.46%	53
2020 Q3	$1.77M	Buy	22,352 +1,069	+5%	+$83.7K	0.51%	48
2020 Q2	$1.57M	Buy	21,283 +402	+2%	+$30.3K	0.49%	49
2020 Q1	$1.53M	Buy	20,881 +1,013	+5%	+$79.6K	0.57%	45
2019 Q4	$1.72M	Sell	19,868 -7,407	-27%	-$608K	0.5%	47
2019 Q3	$2.19M	Buy	27,275 +901	+3%	+$72.2K	0.66%	44
2019 Q2	$2.11M	Sell	26,374 -278	-1%	-$21.3K	0.6%	49
2019 Q1	$2.12M	Sell	26,652 -26,346	-50%	-$1.97M	0.59%	52
2018 Q4	$3.86M	Buy	52,998 +26,185	+98%	+$1.85M	0.61%	50
2018 Q3	$1.81M	Buy	26,813 +132	+0.5%	+$8.41K	0.52%	52
2018 Q2	$1.54M	Sell	26,681 -378	-1%	-$21.3K	0.47%	51
2018 Q1	$1.41M	Sell	27,059 -110	-0.4%	-$5.94K	0.45%	51
2017 Q4	$1.46M	Sell	27,169 -393	-1%	-$21.8K	0.45%	52
2017 Q3	$1.45M	Sell	27,562 -315	-1%	-$19.1K	0.45%	53
2017 Q2	$1.71M	Buy	27,877 +74	+0.3%	+$4.5K	0.56%	49
2017 Q1	$1.69M	Buy	27,803 +586	+2%	+$35.6K	0.57%	50
2016 Q4	$1.53M	Sell	27,217 -78	-0.3%	-$4.57K	0.57%	51
2016 Q3	$1.66M	Sell	27,295 -210	-0.8%	-$12.3K	0.59%	48
2016 Q2	$1.51M	Buy	27,505 +210	+0.8%	+$11.2K	0.57%	49
2016 Q1	$1.38M	Buy	27,295 +1,650	+6%	+$80.8K	0.54%	51
2015 Q4	$1.29M	Sell	25,645 -52	-0.2%	-$2.62K	0.52%	50
2015 Q3	$1.21M	Hold	25,697	–	–	0.49%	50
2015 Q2	$1.4M	Sell	25,697 -733	-3%	-$41.1K	0.52%	49
2015 Q1	$1.45M	Sell	26,430 -71	-0.3%	-$4.02K	0.52%	49
2014 Q4	$1.44M	Sell	26,501 -26	-0.1%	-$1.45K	0.57%	44
2014 Q3	$1.47M	Buy	26,527 +1,931	+8%	+$108K	0.59%	45
2014 Q2	$1.36M	Buy	24,596 +3	+0%	+$164	0.55%	46
2014 Q1	$1.33M	Buy	24,593 +734	+3%	+$38K	0.57%	46
2013 Q4	$1.14M	Sell	23,859 -345	-1%	-$15.8K	0.48%	47
2013 Q3	$1.1M	Sell	24,204 -770	-3%	-$35.2K	0.48%	46
2013 Q2	$1.11M	Buy	+24,974	New	+$1.12M	0.49%	48

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HeadInvest LLC's MRK Position: Q1 2026 in Review

HeadInvest LLC reduced its Merck (MRK) stake by 11% in Q1 2026, selling an estimated $199K and leaving 14,276 shares worth $1.72M. The position accounts for 0.35% of the portfolio, ranked #68.

HeadInvest LLC first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.86M in Q4 2018. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

HeadInvest LLC held 14,276 shares of Merck worth $1.72M as of Q1 2026.
HeadInvest LLC sold 1,722 Merck shares in Q1 2026, an estimated $199K.
Merck made up 0.35% of HeadInvest LLC's portfolio in Q1 2026, its #68 holding.
HeadInvest LLC first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
HeadInvest LLC's Merck position peaked at $3.86M in Q4 2018.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on HeadInvest LLC's 13F filing for Q1 2026, filed 15 May 2026.